All images in this section are for illustration purposes only. Not actual patients or caregivers.

Chronic Sialorrhea in Pediatrics

Demonstrated Safety in Pediatric Patients with Chronic Sialorrhea1

  • Safe and well tolerated, no new or unexpected safety concerns, low rate of dental caries AE
  • No increase of AE incidence with repeated dosing
  • The most frequently reported adverse reaction in patients ages 2–5 years after XEOMIN injections was nasopharyngitis (6%)1


  1. XEOMIN® [Package insert]. Raleigh, NC: Merz Pharmaceuticals, LLC; 2021.